Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.

Malgorzata MikulskaLaura Ambra NicoliniAlessio SignoriAntonio Di BiagioChiara SepulcriChiara RussoSilvia DettoriMarco BerrutiMaria Pia SormaniDaniele Roberto GiacobbeAntonio VenaAndrea De MariaChiara DentoneLucia TaramassoMichele MirabellaLaura MagnascoSara MoraEmanuele DelfinoFederica ToscaniniElisa BallettoAnna Ida AlessandriniFederico BaldiFederica BrianoMarco CameraFerdinando DodiAntonio FerrazinLaura LabateGiovanni MazzarelloRachele PincinoFederica PortunatoStefania TutinoEmanuela BarisioneBianca BruzzoneAndrea OrsiEva SchenoneNirmala RossetiElisabetta SassoGiorgio Da RinPaolo PelosiSabrina BeltraminiMauro GiacominiGiancarlo IcardiAngelo GratarolaMatteo Bassetti

Published in: PloS one (2020)

Early adjunctive treatment with tocilizumab, methylprednisolone or both may improve outcomes in non-intubated patients with COVID-19 pneumonia.

Keyphrases

rheumatoid arthritis
rheumatoid arthritis patients
high dose
metabolic syndrome
skeletal muscle
insulin resistance
extracorporeal membrane oxygenation
respiratory failure
replacement therapy
mechanical ventilation